00_MJ_Intro_Budapest16.pptx

581 / 1173

ARCON phase II trial:
high local control rates in T3-4 tumors
Time (months)
Local control (%)
44 patients
79 patients
21 patients
12 patients
larynx
oropharynx
hypopharynx
oral cavity